##  [Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy](/us-en/news/media-releases/everolimus-rad001-significantly-extends-progression-free-survival-advanced-kidney-cancer-patients-after-failure-other-targeted-therapy-0 "Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy") 

  Feb 28, 2008